comparemela.com

Latest Breaking News On - Florianp thomas - Page 1 : comparemela.com

Pharnext: Findings From Real-World Digital Lifestyle Study, CMT&Me, on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A Published in the Journal of Clinical Neuromuscular Disease

14.09.2022 - PARIS, FRANCE / ACCESSWIRE / September 14, 2022 / Pharnext SA (FR0011191287:ALPHA) (the Company ), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, . Seite 1

Investegate |Pharnext Announcements | Pharnext: Findings From Real-World Digital Lifestyle Study, CMT&Me, on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A Published in the Journal of Clinical Neuromuscular Disease

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.